Pricing Log in Create free account
Saturday 17 October 2026 Export LNTH’s income statement to Excel — free account

Lantheus Holdings, Inc.

LNTH Healthcare Drug Manufacturers Specialty & Generic

Lantheus Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 0.50% from fiscal 2024. In the quarter to June 2026, revenue grew 2.68%, EPS was flat, free cash flow grew 13.6% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years.

99.70 0.29 −0.29%
Market cap
$6.5B
P/E
23.7×
Fwd P/E
25.3×
Dividend yield
—
F-score
5/9
Altman Z
4.25
Beneish M
−2.23
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Lantheus Holdings, Inc. (LNTH) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, Lantheus Holdings, Inc. (LNTH) trades at a P/E ratio of 23.7×. Over the past ten years it has ranged from 0.0× (June 2023) to 202× (March 2023); the current reading is higher than 74% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 19.2× and in line with the Healthcare sector median of 23.0×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 19.3× (2.25%)
FY2024 19.8× 49.93%
FY2023 13.2× (89.32%)
FY2022 124× —
FY2021 0.0× —
FY2020 0.0× —
FY2019 25.3× 71.50%
FY2018 14.8× 131.31%
FY2017 6.4× (38.69%)
FY2016 10.4× —

Quarterly newest first

Period P/E ratio Change
Jun 2026 26.4× 46.26%
Mar 2026 18.0× (6.87%)
Dec 2025 19.3× (7.59%)
Sep 2025 20.9× 0.51%
42 more quarters

Against its own ten years

Low 0.0× High 202×
Ten-year median 17.2×
Current reading's percentile 65

P/E ratio against peers

Company P/E ratio
ELAN Elanco Animal Health Incorporated compare n/m
HIMS Hims & Hers Health, Inc. compare n/m
RGC Regencell Bioscience Holdings Limited compare n/m
INDV Indivior Pharmaceuticals Inc. compare 11.2×
LNTH Lantheus Holdings, Inc. 23.7×
RDY Dr. Reddy's Laboratories Ltd compare 32.9×
AMRX AMNEAL PHARMACEUTICALS, INC. compare 38.4×
KNSA Kiniksa Pharmaceuticals International, plc compare 73.4×
ALKS Alkermes plc compare 102×
Drug Manufacturers Specialty & Generic industry median 19.2×
Healthcare sector median 23.0×
Market median 18.1×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on LNTH